Thoracic Impedance Trend Analysis for Heart Failure Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting congestive heart failure (CHF) decompensation events in patients have limitations in sensitivity, specificity, and predictive value, making timely intervention challenging and leading to unnecessary healthcare costs due to false alarms.
Innovation Solution
An ambulatory medical device with an electrical impedance analyzer circuit and a physiologic event detector circuit calculates a representative impedance value based on thoracic impedance measurements, using a specified percentile to detect impending CHF decompensation events by generating a trend of impedance values over time.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional thoracic impedance monitoring methods are used to detect HF decompensation events, then the detection system can identify fluid accumulation in the lungs, but the sensitivity and specificity of detection remain insufficient leading to false alarms and missed events
Solution Approach 1:
The patent segments the thoracic impedance signal into multiple frequency components using spectral analysis. By dividing the signal into different frequency bands and analyzing each separately, the system can identify specific patterns associated with HF decompensation while filtering out noise and unrelated variations, thereby improving detection accuracy and reducing false alarms.
Solution Approach 2:
The system performs preliminary spectral analysis and pattern recognition on impedance data before making a final decompensation determination. By pre-processing the signal to identify early indicators and establishing baseline patterns, the system can detect subtle changes that precede overt symptoms, improving both sensitivity and specificity of event detection.
2Loss of time
If frequent monitoring of CHF patients is implemented to improve timely detection, then early intervention opportunities increase, but healthcare costs and patient burden increase due to false alarms
Solution Approach 1:
The patent implements a feedback mechanism where detection results are continuously evaluated and used to adjust monitoring parameters and thresholds. The system learns from past events and false alarms, refining its detection algorithm to maintain high sensitivity while reducing false positives, thereby optimizing the balance between timely detection and resource utilization.
Solution Approach 2:
The system dynamically changes monitoring parameters such as impedance thresholds, measurement frequencies, and analysis windows based on patient status and historical data. By adapting parameters in real-time, the system maintains optimal detection sensitivity during high-risk periods while reducing monitoring intensity during stable periods, thus lowering false alarm rates and associated costs.
3Device complexity
If single-sensor detection methods are used for HF decompensation, then device complexity is reduced, but detection sensitivity and applicability across different patients decrease
Solution Approach 1:
The patent makes the impedance analysis system universal by implementing multi-frequency spectral analysis that can detect various physiological patterns using the same basic sensor configuration. The algorithm is designed to identify different event types (decompensation, arrhythmias, respiratory issues) through pattern recognition in the frequency domain, allowing a single device to adapt to diverse patient conditions without requiring additional sensors.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enhances the detection of CHF decompensation events with improved sensitivity and specificity, reducing false alarms and healthcare costs by identifying early precursors of worsening heart failure.
Implementation Method 1
an electrical impedance analyzer circuit and a physiologic event detector circuit that calculate a representative impedance value using a specified percentile of an estimated distribution of thoracic impedance
Implementation Method 2
fluid accumulation in the lungs decreases the transthoracic impedance due to the lower resistivity of the fluid than air in the lungs
Data Source
Figure 1
Figure 2~3
Figure 4
AI summary
Devices and methods for detecting physiological target event such as events indicative of HF decompensation status are described. An ambulatory medical device (AMD) can measure bio-impedance, such as thoracic impedance, from a patient. The AMD can receive a specified threshold within a range or a distribution of impedance measurement, or a specified percentile such as less than 50th percentile, and calculate a representative impedance value (ZRep) corresponding to the specified threshold or percentile using a plurality of thoracic impedance measurements. The representative impedance value can be calculated using an adaptation process, or using an estimated distribution of the impedance measurements. The AMD can include a physiologic event detector circuit that can generate a trend of representative impedance values over a specified time period, and to detect a target physiologic event such as indicative of HF decompensation using the trend of representative impedance values.